← FDA Drug Approvals (Drugs@FDA)

OFLOXACIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MANKIND PHARMA · Approved 2022-11-23

Drug application

FDA Application #

ANDA215886

Application type

Abbreviated New Drug Application (Generic)

Brand name

OFLOXACIN

Generic name

OFLOXACIN

Active ingredients

OFLOXACIN

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

MANKIND PHARMA

Manufacturer

Lifestar Pharma LLC

First approval

2022-11-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown